Mr. Stephen Ooi has had more than 36 year of work experience in the Medical Device industry. Before assuming his current position as Independent Director at XinRong Medical Group, he worked as the Asia Pacific President in Zimmer company (NYSE:ZMH) for 12 years, where he directly managed businesses generating in aggregate more than USD1bn in annual revenue. Mr. Ooi's career spanned more than 30 years at Zimmer, which he joined in 1986. Previously at Zimmer, he was the Vice President of Asia in 1992 and then served as Vice President, Australasia (Asia Pacific excluding Japan) in 2001. He was promoted to the position of President, Asia Pacific Region in 2002 and reported directly to the CEO and President of the Company. He was also a member of the Corporate Senior Management Operating Committee and a Section 16 officer of the Company. Mr. Ooi retired from the Company on December 31, 2016. Prior to Zimmer, Mr. Ooi worked at Johnson & Johnson. Mr. Ooi received his MBA from the National University of Singapore in 1992.

"The opportunities for XinRong Medical in the China market and beyond are exciting. Strong Leadership and strategic focus to win the hearts of customers through strong customer service and quality products are keys to success. The passion of the leadership team in XinRong is clearly palpable and it is my honor and privilege to be given the opportunity to work with the team. It's an exciting time, and with Blackstone's support, we have the right ingredients to be successful in China. I look forward to working with the team," said, Mr. Stephen Ooi, Independent Director of XinRong Medical Group.

"The Chinese Orthopedic market has become one of the world's largest orthopedic markets driven by an aging population, increasing disease prevalence, improving treatment rate and growing affordability. We believe our foremost responsibility is to provide surgeons and patients with products and services that are of the highest quality. We are excited to have Stephen Ooi join the XinRong Medical team. With his rich industry experience and passion in managing talent, we look forward to working closely with Stephen in continuing to grow XinRong Medical as an industry leader," added Ms. Christine (Yu) Zhang, XinRong Medical Group's CEO.

About XinRong Medical Group

XinRong Medical Group, a leader in medical technology, is dedicated to increasing patient affordability and providing the most advanced solutions for surgeons such that they can deliver the best patient care. XinRong Medical offers innovative solutions in orthopedic surgery, neurosurgery, reconstructive surgery, and minimally invasive therapy.

Established in 2000 in Jiangsu Province, China, XinRong Medical was one of the first companies in China cleared by SFDA to manufacture Orthopedic Implants. In 2014, the Company received a strategic investment from The Blackstone Group (NYSE: BX).